AltoLab and Running Performance
- Controlled trial using 29 elite athletes
- Randomized, blind placebo study
- Tested effects of a single 15-day AltoLab IHT Program on running performance
Running Performance after Acutely Intermittent
Simulated Altitude Exposure
MATTHEW R. WOOD, MARTIN N. DOWSON, AND WILL G. HOPKINS
Auckland University of Technology, Auckland 1020, New Zealand
Eur J Sports Sci (2006) 6(3):163-172
Running head: Running performance and intermittent simulated altitude
Address for correspondence:
Will G. Hopkins, PhD
Health Science/Sport and Recreation
Auckland University of Technology
Private Bag 92006, Auckland 1020, New Zealand
- Athletic performance (speed, stamina,
endurance)
- Physiology (peak lactate, lactate speed,
resting and peak heart rate]
- Blood chemistry (hemoglobin,
hematocrit, & white blood cell count)
- Measured results at 3- and 12-days
after AltoLab Program completed and
compared to 1- and 8- days before
AltoLab treatment
|
To do the blind placebo vs. IHT with
the AltoLab the test subjects were
blocked from seeing their blood O2
numbers. The IHT subjects had an
AltoLab fitted with an Hypoxic Silo
and the placebo had the AltoLab
without the Hypoxic Silo. Thus test
subjects did not know if they were
exposed to the IHT treatments or not.
RESULTS
